$451.97
6.961.56%
Last update: Oct 9, 3:45 PM
$443.30
-1.71-0.38%
HCA Healthcare Inc
HCANYSE
HCA Healthcare (HCA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
HCA Healthcare (HCA) last issued guidance on July 24, 2026 for fiscal year 2026. The company guided earnings per share in the range of $28.7 - $30.5, compared to a consensus EPS estimate of $30.17. HCA Healthcare also guided revenue in the range of $77B - $79.5B for the period.
Compared to prior guidance, HCA Healthcare maintained its EPS outlook from a previous range of $28.7 - $30.5. On the revenue side, the company maintained its revenue forecast from a prior range of $77B - $79.5B.
HCA Healthcare has issued 17 guidance updates between January 27, 2023 and July 24, 2026. During this period, the company raised its outlook 8 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $7.41 | $7.16 | $7.42 | $5.70 |
| Actual | $7.59 | $7.15 | $8.01 | $6.96 |
| Surprise | +2.43% | -0.14% | +7.95% | +22.1% |
| Revenue | ||||
| Estimate | $19.37B | $19.07B | $19.66B | $18.54B |
| Actual | $20.23B | $19.11B | $19.51B | $19.16B |
| Surprise | +4.43% | +0.19% | -0.74% | +3.37% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $6.67 | $8.06 | $7.66 | $8.07 |
| Revenue | ||||
| Consensus | $19.36B | $19.88B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 24, 2026 | $7.59 | $7.41 | 2.43 % |
| Q1 | Apr 24, 2026 | $7.15 | $7.16 | -0.14 % |
| Q4 | Jan 27, 2026 | $8.01 | $7.42 | 7.95 % |
| Q3 | Oct 24, 2025 | $6.96 | $5.70 | 22.1 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 24, 2026 | $20.23B | $19.37B | 4.43 % |
| Q1 | Apr 24, 2026 | $19.11B | $19.07B | 0.19 % |
| Q4 | Jan 27, 2026 | $19.51B | $19.66B | -0.74 % |
| Q3 | Oct 24, 2025 | $19.16B | $18.54B | 3.37 % |
